A European partner in Life Science

Our vision is to improve people's lives by being a leading, value-adding partner in Life Science

INTERIM REPORT Q3 2024
Graph

Share price

2024-11-13

Press Releases

Calendar

  • Looking for an Europan distributor?

    Our subsidiaries partner with many of the most respected Medtech and Labtech global brands to deliver sales, marketing, education, logistics and technical services solutions across Europe.

    At AddLife, we are committed to investing in new partnerships. Please contact us and discuss your distribution needs in Europe

    Contact
    Photo Template
  • Organic growth and stable margin

    Continued organic growth and stable margin in the third quarter - a quarter that is normally somewhat weaker seasonally. The work on profitability improvements is progressing according to plan. 

    comments by the ceo
    1 Fredrik Dalborg Q3 2024
  • AddLife acquires BonsaiLab

    BonsaiLab is a leading Spanish distributor in the field of cell and molecular biology. The company’s offering includes cutting-edge technology products, analytical solutions, and services for genomics laboratories in Spain and Portugal, including products for next generation sequencing, genomic analysis as well as sample preparation. The company, with current revenues of EUR 8 m, has 13 employees and will be included in AddLife’s business area Labtech.

    To Bonsailab
    Adobestock 670238669
  • Improving people´s lives

    Watch Video
    Improving Peoples Lives Youtube

Our business areas

Medtech

MEDTECH

In the Medtech business area, the subsidiaries offer products and services in medical technology, as well as assistive equipment and digital solutions for use in home care. Medtech has two business units - Hospital and Homecare. The Medtech offering mainly focuses on publicly funded healthcare, home care and social care in Europe.

Read more
Labtech

LABTECH

The Labtech business area provides products, solutions and services in fields such as diagnostics, biomedical research and laboratory analysis. The business area consists of two business units: Biomedical and Research and Diagnostics. The most important customer groups are hospital laboratories, academic research and pharmaceutical companies in Europe.

Read more

Join the AddLife group

Do you have a Life Science company with opportunities to grow? We offer an attractive option with a decentralized business model where we combine the strength of a large enterprise with the dedication and business skills of an entrepreneur. As an AddLife subsidiary, you are responsible for your business activities within the AddLife requirements for growth, profitability and sustainable development.

Acquisitions

News from our subsidiaries

Ropox Award 2024
11 November 2024
Ropox Prize 2024

We are truly committed to making a difference for people with disabilities, and we also endeavor to reward those who share this mission.

Ropox
05 November 2024 | Hepro
Hepro designs and manufactures high-quality products

At AddLife AB, our home care companies offer products and services that improve daily independence.

29 October 2024 | Triolab AS
We want to improve our way of working with sustainability

Sustainability is a central part of our vision to improve people's lives. Our commitment to improving people's lives is not just our slogan; it is an integral part of our daily operations and a cornerstone of our long-term strategy.

21 October 2024 | Triolab OY
Environmental certificate

Triolab Oy has been awarded the ISO 14001 environmental certificate. What is it and how does it affect Triolab’s operations?

See all news

Sustainability for AddLife

Sustainability is a central part of AddLife's vision to improve people's life by being a leading, value adding provider in Life Science. AddLife´s approach to sustainability is identified through three impact areas where we can have the greatest contribution to a long-term lasting business and society.

Adobestock 300716540